Icosavax Inc (ICVX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Sales | 0 | 582 | 2,070 | 1,827 | 1,904 |
| Gross Profit | N/A | 582 | 2,070 | 1,827 | 1,904 |
| Operating Expenses | 23,131 | 24,235 | 20,281 | 36,240 | 10,498 |
| Operating Income | -23,131 | -23,653 | -18,211 | -34,413 | -8,594 |
| Other Income | 495 | 120 | 29 | 27 | 42 |
| Pre-tax Income | -22,636 | -23,533 | -18,182 | -34,386 | -8,552 |
| Net Income Continuous | -22,636 | -23,533 | -18,182 | -34,386 | -8,552 |
| Net Income | $-22,636 | $-23,533 | $-18,182 | $-34,386 | $-8,552 |
| EPS Basic Total Ops | -0.57 | -0.60 | 2.54 | -1.30 | -2.86 |
| EPS Basic Continuous Ops | -0.57 | -0.60 | 2.55 | -1.30 | -2.87 |
| EPS Diluted Total Ops | -0.57 | -0.60 | 2.54 | -1.30 | -2.86 |
| EPS Diluted Continuous Ops | -0.57 | -0.60 | 2.55 | -1.30 | -2.87 |
| EPS Diluted Before Non-Recurring Items | -0.57 | -0.60 | -0.46 | N/A | N/A |
| EBITDA(a) | $-23,265 | $-23,610 | $-18,175 | $-34,384 | $-8,578 |